Negative regulation of interleukin-1 alpha production

pathway activity — cross-omics
GO:0032690Cross-omicsSHRNA → DRUGCellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of interleukin-1 alpha production pathway is significantly associated with the drug response of multiple features, with the LUNG_SCLC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated features across cancer lineages are KIN001-270, BIX02189, and Ispinesib Mesylate, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, KIN001-270 grouped by Negative regulation of interleukin-1 alpha production-low versus -high activity in LUNG_SCLC.

Pathway-associated features by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner featureX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUNG_SCLCKIN001-270 →+0.388+1.489.016.01236
OVARYBIX02189 →+0.452+1.249.002.00536
SKINIspinesib Mesylate →+0.757+1.182.002.00636
SOFT_TISSUENiraparib →+0.975+2.071.017.00926
SOFT_TISSUEZoledronate →+0.799+2.516.014.00635
OVARYLMB_AB1 →+0.532+1.979.031.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

KIN001-270 by Negative regulation of interleukin-1 alpha production activity — LUNG_SCLC

Box plot of KIN001-270 in Negative regulation of interleukin-1 alpha production-low vs -high samples in LUNG_SCLC.

Explore this box plot interactively →

Exploration